United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

global medical supplychain llc belgium - 1 vial + 1 sterile transfer device + 1 sterile intravenous infusion set + 1 sterile short catheter - infusion - 5g / vial - antidotes-natural source - see indication field for description

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

modern pharmaceutical company sweden - 30 sachets - suspension - 5 g/sachet - nutrition , blood-fluids , electrolytes

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc united states of america - 60's (5 g packet x 60) - solution - 5 g/packet - nutrition , blood-anaemia , other blood disorders

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmalink store italy - 1 glass vial (25 ml) - infusion - 5 g/ 25 ml - antidotes-n/a

New Zealand - English - Medsafe (Medicines Safety Authority)

specialised therapeutics limited - aminolevulinic acid hydrochloride 1.5 g - powder for oral solution - 1.5 g - active: aminolevulinic acid hydrochloride 1.5 g - gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant gliomas that are glioblastoma multiforme (gbm) on preoperative imaging , and who are intended for resection of the tumour.

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c spain - 1 pre-filled applicator (5 g) - gel - 65 mg/5 g - infections-antibacterial

Kenya - English - Pharmacy and Poisons Board

barichem pharmaceuticals ltd p.o.box 46824-00100,nairobi - piperacillin 4g-tazobactam 0.5g - powder for injection - 4.5g - beta-lactamantibacterials: combinations of

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).

Canada - English - Health Canada

laboratoires clarins - octinoxate; avobenzone; oxybenzone; octisalate - emulsion - 7.5g; 2g; 5g; 5g - octinoxate 7.5g; avobenzone 2g; oxybenzone 5g; octisalate 5g - sunscreen agents

Canada - English - Health Canada

laboratoires clarins - octinoxate; octocrylene; oxybenzone; octisalate - spray - 7.5g; 7g; 5g; 5g - octinoxate 7.5g; octocrylene 7g; oxybenzone 5g; octisalate 5g - sunscreen agents